Korro Bio Inc. (KRRO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Korro Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$13.86
+4.21% today
Market cap
$196M
Overall quality
—
Kronos AI 30-day
−7.0%
1 of 8 simulated paths end higher
Korro Bio Inc. (KRRO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $196M. It trades at $13.86, up 4.21% today. 9 analysts' average target of $19.33 implies +39.5% from today's price. Kronos AI's 30-day forecast is −7.0% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $19.33 |
| Low – high | $10.00 – $30.00 |
| Analysts | 9 |
| Upside to average | +39.5% |
Kronos AI 30-day forecast
| Expected close | $12.37 (−7.0%) |
| Likely range | −18.0% … −1.3% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.